Article Text

Download PDFPDF

Editorial commentary
‘It’s the progression, doctor’: what patients with motor neurone disease really are interested in
  1. Julian Grosskreutz
  1. Correspondence to Dr Julian Grosskreutz, Hans Berger Department of Neurology, Jena University Hospital, Am Klinikum 1, Jena 07747, Germany; julian.grosskreutz{at}med.uni-jena.de

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

To see a patient and recognise amyotrophic lateral sclerosis as the underlying cause of progressive, painless paralysis without sensory symptoms has been deemed easy, and indeed it is for physicians seeing patients with motor neuron disease on a regular basis. Answering patients’ questions of ‘How bad is it? What will happen to me? How long do I have?’ is however no mean feat; these questions invariably challenge the treating physician to perform a thorough assessment of the extent and the aggressiveness of the disease. While the Amyotrophic lateral sclerosisfunctional rating scale (ALSFRS-R) provides a quantitative measure of functional deficits, it does not follow a linear time course …

View Full Text

Linked Articles

  • Neurodegeneration
    Joe Senda Naoki Atsuta Hirohisa Watanabe Epifanio Bagarinao Kazunori Imai Daichi Yokoi Yuichi Riku Michihito Masuda Ryoichi Nakamura Hazuki Watanabe Mizuki Ito Masahisa Katsuno Shinji Naganawa Gen Sobue